JP2018530766A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530766A5
JP2018530766A5 JP2018537693A JP2018537693A JP2018530766A5 JP 2018530766 A5 JP2018530766 A5 JP 2018530766A5 JP 2018537693 A JP2018537693 A JP 2018537693A JP 2018537693 A JP2018537693 A JP 2018537693A JP 2018530766 A5 JP2018530766 A5 JP 2018530766A5
Authority
JP
Japan
Prior art keywords
configuration
proteins
protein profile
sample
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018537693A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530766A (ja
JP6824994B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/000341 external-priority patent/WO2017059477A1/en
Publication of JP2018530766A publication Critical patent/JP2018530766A/ja
Publication of JP2018530766A5 publication Critical patent/JP2018530766A5/ja
Application granted granted Critical
Publication of JP6824994B2 publication Critical patent/JP6824994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018537693A 2015-10-07 2016-10-06 血液の調製及びプロファイリング Active JP6824994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015904075A AU2015904075A0 (en) 2015-10-07 Blood preparation and profiling
AU2015904075 2015-10-07
PCT/AU2016/000341 WO2017059477A1 (en) 2015-10-07 2016-10-06 Blood preparation and profiling

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021003537A Division JP2021073453A (ja) 2015-10-07 2021-01-13 血液の調製及びプロファイリング

Publications (3)

Publication Number Publication Date
JP2018530766A JP2018530766A (ja) 2018-10-18
JP2018530766A5 true JP2018530766A5 (cg-RX-API-DMAC7.html) 2019-11-14
JP6824994B2 JP6824994B2 (ja) 2021-02-03

Family

ID=58487130

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018537693A Active JP6824994B2 (ja) 2015-10-07 2016-10-06 血液の調製及びプロファイリング
JP2021003537A Pending JP2021073453A (ja) 2015-10-07 2021-01-13 血液の調製及びプロファイリング
JP2023034247A Pending JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021003537A Pending JP2021073453A (ja) 2015-10-07 2021-01-13 血液の調製及びプロファイリング
JP2023034247A Pending JP2023078210A (ja) 2015-10-07 2023-03-07 血液の調製及びプロファイリング

Country Status (10)

Country Link
US (2) US11243218B2 (cg-RX-API-DMAC7.html)
EP (2) EP3359962B1 (cg-RX-API-DMAC7.html)
JP (3) JP6824994B2 (cg-RX-API-DMAC7.html)
KR (1) KR102632490B1 (cg-RX-API-DMAC7.html)
CN (2) CN114019171A (cg-RX-API-DMAC7.html)
AU (1) AU2016334875B2 (cg-RX-API-DMAC7.html)
CA (1) CA3001154C (cg-RX-API-DMAC7.html)
HK (1) HK1258470A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201802754XA (cg-RX-API-DMAC7.html)
WO (1) WO2017059477A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016374643B2 (en) * 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
US20240352423A1 (en) * 2021-03-10 2024-10-24 Terasaki Institute For Biomedical Innovation Methods and systems of producing products such as animal derived products
CN114081899A (zh) * 2021-11-02 2022-02-25 四川大学华西医院 一种富白细胞富血小板血浆的制备方法
JP7772425B2 (ja) 2022-03-23 2025-11-18 株式会社ミルテル ニコチンアミドアデニンジヌクレオチド(nad+)又はニコチンアミドモノヌクレオチド(nmn)を定量する方法、並びにその方法を実施するためのキット及び濾紙
WO2024010763A1 (en) * 2022-07-07 2024-01-11 Russell Biotech, Inc. Preparation of platelet free mononuclear cells

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931276A (en) 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
WO1992005801A1 (en) 1990-10-04 1992-04-16 University Of Virginia Alumni Patents Foundation Primate erythrocyte bound monoclonal antibody heteropolymers
PT706799E (pt) * 1994-09-16 2002-05-31 Merck Patent Gmbh Imunoconjugados ii
US5763280A (en) * 1997-01-21 1998-06-09 Coulter International Corp. Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
FR2778851B1 (fr) 1998-05-19 2002-07-26 Aetsrn Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
US8431117B2 (en) 1999-08-30 2013-04-30 David S Terman Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
EP1355656A2 (en) 2000-07-24 2003-10-29 Gendel Limited Red blood cell as vehicle for agent-membrane translocation sequence conjugate
ES2498369T3 (es) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Un marcador para medir cirrosis hepática
US7501286B2 (en) 2002-08-14 2009-03-10 President And Fellows Of Harvard College Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry
US7276382B2 (en) * 2003-10-02 2007-10-02 Noboru Horiguchi Blood testing method
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US7378054B2 (en) 2004-04-16 2008-05-27 Savvipharm Inc Specimen collecting, processing and analytical assembly
US7803523B2 (en) * 2004-08-27 2010-09-28 University Health Network Whole blood preparation for cytometric analysis of cell signaling pathways
US20060166223A1 (en) * 2005-01-26 2006-07-27 Reed Michael W DNA purification and analysis on nanoengineered surfaces
WO2006123253A2 (en) 2005-03-29 2006-11-23 Inverness Medical Switzerland Gmbh Device and method of monitoring a patient
US20100184049A1 (en) 2007-04-27 2010-07-22 Steve Goodison Glycoprotein Profiling of Bladder Cancer
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
US8530182B2 (en) 2007-12-05 2013-09-10 Centers For Disease Control And Prevention Viral protein quantification process and vaccine quality control therewith
CN102037355A (zh) 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
US20110086424A1 (en) 2008-05-06 2011-04-14 Advanced Cell Technology, Inc. Methods for producing enucleated erythroid cells derived from pluripotent stem cells
WO2010147621A1 (en) 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells
SG177407A1 (en) * 2009-06-30 2012-02-28 Kaneka Corp Blood component separation system and separation material
CA2769889A1 (en) * 2009-08-13 2011-02-17 Basf Se Means and methods for diagnosing thyroid disorders
WO2011091154A2 (en) 2010-01-21 2011-07-28 The Regents Of The University Of California Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
AU2011212477A1 (en) 2010-02-08 2012-08-30 Piramal Imaging Sa F18-tyrosine derivatives for imaging bone metastases
WO2011127056A2 (en) 2010-04-05 2011-10-13 The Uab Research Foundation Biomarkers for assessing exposure to ionizing radiation and absorbed dose
US20150111238A1 (en) 2011-05-31 2015-04-23 Singapore Health Services Pte. Ltd. Method for detecting disease biomarkers
GB201116767D0 (en) 2011-09-28 2011-11-09 St George S Hospital Medical School Treatment for mitrochondrial neurogastrointestinal encephalomyopathy
US20150086521A1 (en) 2012-03-21 2015-03-26 Erytech Pharma Medicament for the Treatment of Acute Myeloid Leukemia (AML)
HU230341B1 (hu) * 2012-04-20 2016-02-29 Advancell Diagnosztika Kft. A vörösvérsejt-membrán kvantitatív biomarkerei
WO2014011901A2 (en) 2012-07-11 2014-01-16 Sangamo Biosciences, Inc. Methods and compositions for delivery of biologics
CN105228596B (zh) 2013-05-10 2018-08-24 爱瑞德勒股份有限公司 用于制备载有一种或多种制药学感兴趣物质的红细胞的方法和由此得到的红细胞
JP6383920B2 (ja) * 2013-09-11 2018-09-05 有限会社ピコデバイス パーキンソン病の判定基準とする方法
KR20160073382A (ko) * 2013-10-04 2016-06-24 셀 아이디어스 피티와이 엘티디 세포 치료를 위한 바이오마커들
KR101845588B1 (ko) 2014-04-07 2018-04-05 한양대학교 산학협력단 적혈구계 세포의 인 비트로 확장
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
AU2016374643B2 (en) 2015-12-22 2023-12-14 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
JP2020502545A (ja) 2016-12-20 2020-01-23 サングイ バイオ ピーティーワイ. エルティーディー プロテアーゼインヒビターを用いる血液プロファイリング

Similar Documents

Publication Publication Date Title
Uzawa et al. CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse
JP2021073453A5 (cg-RX-API-DMAC7.html)
Stenken et al. Bioanalytical chemistry of cytokines–a review
Sahibzada et al. Salivary IL-8, IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer
Kabashima et al. Increased circulating Th17 frequencies and serum IL‐22 levels in patients with acute generalized exanthematous pustulosis
Zhao et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring
Doerflinger et al. Procalcitonin and interleukin-10 may assist in early prediction of bacteraemia in children with cancer and febrile neutropenia
JP2020502545A5 (cg-RX-API-DMAC7.html)
Kumboyono et al. The potential predictive role of tumour necrosis factor-α, interleukin-1β, and monocyte chemoattractant protein-1 for COVID-19 patients survival
Boby et al. Divergent cytokine and chemokine responses at early acute simian immunodeficiency virus infection correlated with virus replication and CD4 T cell loss in a rhesus macaque model
Lebedeva et al. Comprehensive cytokine profiling of patients with COVID-19 receiving tocilizumab therapy
Smolnikova et al. Immunological markers of uncontrolled atopic bronchial asthma in children
Mondell et al. Immune Biomarkers at Birth Predict Lower Respiratory Tract Infection Risk in a Large Birth Cohort
Pavletič et al. Upregulated intrathecal expression of VEGF-A and long lasting global upregulation of proinflammatory immune mediators in vaccine breakthrough tick-borne encephalitis
Iablonskiy et al. ROLE OF MODERN IMMUNOLOGIC TESTS IN DIAGNOSTICS OF TUBERCULOSIS IN CHILDREN
CN102524168B (zh) 一种蛋鸭抗病力的综合评定选择方法
Prokhorenko et al. Significance of inflammation markers determined in pregnant women with anemic syndrome and obesity
JP2013525820A5 (cg-RX-API-DMAC7.html)
Polushina et al. Clinico-pathogenetic value of some cytokines in periodontitis
Semenov et al. The role of cytokines and chemokines in laboratory diagnostic of chronic viral hepatitis C
RU2017132274A (ru) Способы диагностирования хронического заболевания клапанов
Νάκου Investigation of pathogenesis, clinical course, prognosis and response to therapy of systemic lupus erythematosus: perspective and comparative study using DNA microarrays in bone marrow and peripheral blood samples
CN205484360U (zh) 半定量快速检测狂犬病毒抗体的试纸带
LIU et al. An analysis of serum levels of cytokines and relative factors in depression patients
Ebraheem Cytokines as a Serum Immunological Markers for Follow up of Pulmonary Tuberculosis During Therapy